NEUROENDOCRINE NEOPLASM
Clinical trials for NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink hard-to-treat liver tumors
Disease control OngoingThis study tests whether adding an immunotherapy drug (pembrolizumab) to either liver-directed treatments or a type of radiation therapy (PRRT) can shrink tumors in people with advanced neuroendocrine tumors that have spread to the liver. About 32 adults with well-differentiated …
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: Nicholas Fidelman, MD • Aim: Disease control
Last updated Apr 29, 2026 01:51 UTC
-
New drug shows promise in slowing neuroendocrine tumor growth
Disease control OngoingThis study tests whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors (including carcinoid tumors) compared to a placebo. About 298 adults whose tumors worsened after prior treatment will receive either cabozantinib or a placebo. The goal is to see …
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 01:49 UTC